Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

One-hit effects and cancer.

Iniesta MD, Chien J, Wicha M, Merajver SD.

Cancer Prev Res (Phila). 2010 Jan;3(1):12-5. doi: 10.1158/1940-6207.CAPR-09-0249. Review.

PMID:
20051368
[PubMed - indexed for MEDLINE]
2.

Genomic rearrangements in the BRCA1 and BRCA2 genes.

Mazoyer S.

Hum Mutat. 2005 May;25(5):415-22. Review.

PMID:
15832305
[PubMed - indexed for MEDLINE]
3.

[Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy].

Levanat S, Cvok ML.

Lijec Vjesn. 2010 Jan-Feb;132(1-2):34-7. Review. Croatian.

PMID:
20359158
[PubMed - indexed for MEDLINE]
4.

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.

Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, Leenders EP, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg MJ, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk JC.

J Med Genet. 2005 Mar;42(3):e20. Review. No abstract available.

PMID:
15744030
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.

Grenader T, Peretz T, Lifchitz M, Shavit L.

Breast. 2005 Aug;14(4):264-8. Review.

PMID:
16085232
[PubMed - indexed for MEDLINE]
6.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
[PubMed - indexed for MEDLINE]
7.

Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.

Swisher E.

Curr Womens Health Rep. 2003 Feb;3(1):27-32. Review.

PMID:
12521547
[PubMed - indexed for MEDLINE]
8.

Mutations of BRCA genes in hereditary breast and ovarian cancer.

Radice P.

J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):9-12. Review.

PMID:
12585647
[PubMed - indexed for MEDLINE]
9.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.

Wolff TA, Wilson JE.

Am Fam Physician. 2006 Nov 15;74(10):1759-60. Review. No abstract available.

PMID:
17137007
[PubMed - indexed for MEDLINE]
Free Article
10.

BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.

O'Donovan PJ, Livingston DM.

Carcinogenesis. 2010 Jun;31(6):961-7. doi: 10.1093/carcin/bgq069. Epub 2010 Apr 16. Review.

PMID:
20400477
[PubMed - indexed for MEDLINE]
Free Article
11.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Welcsh PL, King MC.

Hum Mol Genet. 2001 Apr;10(7):705-13. Review.

PMID:
11257103
[PubMed - indexed for MEDLINE]
Free Article
12.

Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

Kauff ND, Barakat RR.

J Clin Oncol. 2007 Jul 10;25(20):2921-7. Review.

PMID:
17617523
[PubMed - indexed for MEDLINE]
13.

Susceptibility pathways in Fanconi's anemia and breast cancer.

D'Andrea AD.

N Engl J Med. 2010 May 20;362(20):1909-19. doi: 10.1056/NEJMra0809889. Review. No abstract available.

PMID:
20484397
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk